Medibio Ltd. said Kris Knauer resigned from its board.
The company said Knauer resigned due to pressure from his other executive and nonexecutive roles.
Knauer served as CEO of Medibio from September 2014 to Feb. 16, 2017.
Medibio nonexecutive director resigns
COVID-19 Pandemic Likely To Cause US Telemedicine Boom
Gauging Supply Chain Risk In Volatile Times
Cannabis: Hashing Out a Budding Industry
IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help
Medibio nonexecutive director resigns
- Author Vince Iral
- Theme Healthcare & Pharmaceuticals
- Author
- Vince Iral
- Theme
- Healthcare & Pharmaceuticals